Simvastatin

A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL.

1,000 PubMed studies analyzed · 605 RCTs · Evidence Score: 71.8

Research Domains

Simvastatin has been studied across 22 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 😴 Sleep, 🫁 Liver & Detox, 🦴 Bone & Joint. The primary research focus is ❤️ Cardiovascular with 52% of studies addressing this area.

Loading evidence profile...

This evidence profile for Simvastatin is generated deterministically from 1,000 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.